Hormone replacement therapy in healthy BRCA1 and 2 mutation carriers after risk-reducing salpingo-oophorectomy: A 5 Ws and 2 Hs practitioner toolkit [0.03%]
健康BRCA1和BRCA2突变携带者风险降低型输卵管卵巢切除术后的激素替代疗法：实践工具包（5W’s和2H’s）
Valentina Elisabetta Bounous,Noemi Andronico,Giulia Lavalle et al.
Valentina Elisabetta Bounous et al.
The management of menopausal symptoms in healthy women carrying BRCA1 or BRCA2 mutations is clinically challenging, particularly in those undergoing risk-reducing salpingo-oophorectomy. This preventive surgery is recommended because it lowe...
Arselda Lala,Lum Kastrati,Taulant Muka
Arselda Lala
Whole-person strengths, challenges, and needs across the reproductive lifespan: A cross-sectional consumer-generated health data study [0.03%]
生命周期生殖阶段的全方位优势、挑战和需求：一项基于消费者生成的健康数据横断面研究
Robin R Austin,Meijia Song,Malin Britt Lalich et al.
Robin R Austin et al.
Objectives: The reproductive lifespan encompasses important transitions in women's health, including midlife and menopause, yet whole-person strengths, challenges, and unmet needs across this continuum remain poorly chara...
SPPB or chair stand test: Which is associated with mortality risk in high-functioning older adults? [0.03%]
步态速度和椅子站立测试哪项与高功能老年人的死亡率相关？
Roberta de Oliveira Máximo,Mariane Marques Luiz,Andrew Steptoe et al.
Roberta de Oliveira Máximo et al.
Objective: To investigate the associations of the Short Physical Performance Battery (SPPB) and the Chair Stand Test (CST) with all-cause mortality risk among high-functioning older adults over a 15-year follow-up. ...
Are we teaching yesterday's medicine? Rethinking women's health education [0.03%]
我们还在教“昨天的医术”么？ 重新思考女性健康教育
Grisela Prenga,Taulant Muka
Grisela Prenga
Menopause is rarely coded in the emergency department: A real-world study of 413,414 visits by women aged 40-65 years (the MIMOSA study) [0.03%]
急诊科罕见将更年期进行编码：一项关于40至65岁女性413,414次就诊的真实世界研究（MIMOSA研究）
Caroline Cabral Kanaan,Mateus de Lima Freitas,Adriano José Pereira et al.
Caroline Cabral Kanaan et al.
Objectives: To quantify how often menopause is captured by diagnostic coding among women aged 40 to 65 attending the emergency department with potentially menopause-related symptoms, to characterise their presentation, an...
Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program [0.03%]
评估elinzanetant对绝经相关血管舒缩症状和睡眠障碍疗效和安全性的一致性：OASIS临床试验项目的系统评价
JoAnn V Pinkerton,James A Simon,Nick Panay et al.
JoAnn V Pinkerton et al.
Elinzanetant, a dual neurokinin-1/-3 receptor antagonist, is approved for the treatment of moderate-to-severe vasomotor symptoms. The double-blind, randomized, placebo-controlled Phase III OASIS-1-4 studies evaluated elinzanetant's efficacy...
'Healthy menopause': The European menopause and andropause society (EMAS) 2026 framework for precision, digital, and interdisciplinary midlife health [0.03%]
“健康更年期”：欧洲更年期和男性更年期学会（EMAS）精准医学、数字技术和跨学科协作促进中年健康的2026框架
Petra Stute,Elena Pavicic,Eleni Armeni et al.
Petra Stute et al.
Introduction: On average, women now spend more than one-third of their lives in the post-reproductive period, yet menopause care across Europe remains fragmented and uneven. Since the first publication of its model of car...
Menopausal hormone therapy and incident benign paroxysmal positional vertigo in postmenopausal women: A prospective cohort study using UK Biobank data [0.03%]
绝经后激素治疗与绝经后女性良性阵发性位置性眩晕发病的关系：一项使用英国生物样本库数据的前瞻性队列研究
Li Li,Jingyun Chen,Xu Han et al.
Li Li et al.
Objectives: Menopausal hormone therapy and benign paroxysmal positional vertigo, a disorder linked to postmenopausal estrogen deficiency, have not been examined together in a large cohort. We assessed whether hormone ther...
Association of perinatal depression with vasomotor symptoms during midlife: A prospective community-based cohort study [0.03%]
围产期抑郁与更年期期间血管运动症状的相关性：一项前瞻性社区队列研究
Rebecca A Manion,Erin A Brennand,Beili Huang et al.
Rebecca A Manion et al.
Objectives: To explore the association between perinatal depression and midlife vasomotor symptoms. Study design: We analyzed a subset ...